Stem Cell Therapies - How to Get to Market
Joyce Frey-Vasconcells, Director, PharmaNet Development Group, speaking at Stem Cells Europe 2010.
Rem2 GTPase is a Critical Mediator of the Pluripotency/Differentiation Switch in the Developing Embryo by Regulating the Cell Cycle and Apoptosis
Michael Edel, Carlos III Principle Investigator, Center of Regenerative Medicine, speaking at Stem Cells Europe 2010.
Mesenchymal Stem Cells From Wharton’s Jelly of the Umbilical Cord: An Exciting New Cell Source for Musculoskeletal Tissue Regeneration?
Michael Detamore, Associate Professor, University of Kansas, speaking at Stem Cells Europe 2010.
Homogeneous, Bioluminescent Assays for the Mechanistic Assessment of Toxicity of iPS Cardiomyocytes
Mie Cong, R&D Research Manager, Promega, speaking at Stem Cells Europe 2010.
P38MAPK Controls the Early Commitment of Embryonic Stem Cells Towards Mesodermal Lineages
Bernard Binetruy, Researcher, Inserm, speaking at Stem Cells Europe 2010.
Stem Cell Recruitment as a Strategy for Tissue Repair
Daniel Peterson, Executive Director, Rosalind Franklin University of Medicine and Science, Speaking at Stem Cells World Congress 2010.
Sensitive and High Throughput Multiplexed Immunoassays for Biomarker Discovery in Biobanked Samples Using Proximity Ligation Assays and qPCR
Simon Fredriksson, Chief Scientific Officer, Olink Bioscience, speaking at European Biomarkers Summit 2009
Human Embryonic Stem Cell Therapy: Pathway to the Clinic
Thomas Okarma, President, Geron, Speaking at Stem Cells World Congress 2010.
Using Mesenchymal Stem Cells as Vehicles to Deliver Neurorestorative Therapies
Jan Nolta, Director, UC Davis, Speaking at Stem Cells World Congress 2010.